{"id":"W2921549035","doi":"10.14309/00000434-201810001-02049","title":"Use of Oral Low-dose Cyclophosphamide Therapy in Patients With Refractory Extensive Crohnʼs Disease","year":2018,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Azathioprine; Prednisone; Infliximab; Crohn's disease; Internal medicine; Gastroenterology; Adalimumab; Inflammatory bowel disease; Methotrexate; Nausea; Surgery; Cyclophosphamide; Disease; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001325587,0.0002150105,0.0004144848,0.0005235922,0.0005044028,0.0003665137,0.0001453139,0.0004121994,0.001984882],"category_scores_gemma":[0.0007288529,0.00007356363,0.0002521634,0.0004536436,0.0002366515,0.000259596,0.0001862698,0.0004387753,0.0002519029],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002709915,"about_ca_system_score_gemma":0.0003035389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001226284,"about_ca_topic_score_gemma":0.002402633,"domain_scores_codex":[0.9998755,0.00002427603,0.00001810574,0.0000170184,0.000026773,0.00003818581],"domain_scores_gemma":[0.9997278,0.00007181441,0.0000844445,0.000006686907,0.00001967754,0.00008956869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.001104502,0.0004119719,0.7407159,0.0006629777,0.0001464698,0.1282504,0.0004869876,0.0002608587,0.006367846,0.0002797144,0.00375864,0.1175536],"study_design_scores_gemma":[0.0002236391,0.001580986,0.5451705,0.001132243,0.0003380464,0.4246376,0.0009739121,0.0008824192,0.001695984,0.000555262,0.02276698,0.00004252101],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9427761,0.03982825,0.0004377969,0.001653862,0.0001320441,0.00005378532,0.0001263083,0.00003853689,0.01495335],"genre_scores_gemma":[0.9937446,0.004588448,0.0002948799,0.0005317378,0.0001579113,0.00001197414,0.0001146263,0.000003646698,0.0005522358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001984882,"threshold_uncertainty_score":0.006640136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00685478282852311,"score_gpt":0.2266035225985541,"score_spread":0.219748739770031,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}